Diabetes and Immunology

Type 1 diabetes is a chronic T-cell mediated disease that leads to the destruction of the insulin-secreting islet β-cells resulting in absolute insulin deficiency and hyperglycaemia. The clinical presentation of T1D is preceded by an asymptomatic period lasting from months to years which is characterised by autoantibodies against islet β-cell components. Insulin autoantibodies are amongst the first to appear, followed by autoantibodies to glutamic acid decarboxylase and then spreading to IA-2 (insulinoma-associated tyrosine phosphatase protein) and ZnT8 (zinc-transporter 8).

  • Islet cell auto-antigens
  • Immune cells
  • Therapies using immune modulators
  • Vaccination

Related Conference of Diabetes and Immunology

July 17-18, 2017

18th European Diabetes Congress

Lisbon, Portugal
July 20-22, 2017

19thAsia Pacific Diabetes Conference

Melbourne, Australia
July 24-26,2017

10th Diabetologists Conference

Vancouver, Canada
September 11-12, 2017

9th Annual Congress on Endocrine Disorders and Therapies


(10 Plenary Forums - 1 Event)
Dallas, Texas, USA
September 20-22, 2017

International Conference on Diabetes and Diabetic Nursing Care

Charlotte, North Carolina, USA
October 02-04, 2017

Diabetes and Endocrinology Congress

Osaka, Japan
October 30-November 01, 2017

10th International Conference on Endocrinology

Chicago, Illinois, USA
December 11-12, 2017

25th Global Diabetes Summit and Medicare Expo

Dubai, UAE
February 12-13,2018

7th European Diabetes and Endocrinology Congress

Munich, Germany

Diabetes and Immunology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in